Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 87

  • Showing results for diindolylmethane breast cancer. Your search for diindolemethane breast cancer retrieved no results.
1.

AHR/CYP1A1 interplay triggers lymphatic barrier breaching in breast cancer spheroids by inducing 12(S)-HETE synthesis.

Nguyen CH, Brenner S, Huttary N, Atanasov AG, Dirsch VM, Chatuphonprasert W, Holzner S, Stadler S, Riha J, Krieger S, de Martin R, Bago-Horvath Z, Krupitza G, Jäger W.

Hum Mol Genet. 2016 Sep 27. pii: ddw329. [Epub ahead of print]

PMID:
27677308
2.

Novel Diindolylmethane derivatives based NLC formulations to improve the oral Bioavailability and anticancer effects in Triple Negative Breast Cancer.

Godugu C, Doddapaneni R, Safe SH, Singh M.

Eur J Pharm Biopharm. 2016 Aug 29. pii: S0939-6411(16)30433-7. doi: 10.1016/j.ejpb.2016.08.006. [Epub ahead of print]

PMID:
27586082
3.
5.

Chemopreventive properties of 3,3'-diindolylmethane in breast cancer: evidence from experimental and human studies.

Thomson CA, Ho E, Strom MB.

Nutr Rev. 2016 Jul;74(7):432-43. doi: 10.1093/nutrit/nuw010.

PMID:
27261275
6.

The estrogenic effect of trigonelline and 3,3-diindolymethane on cell growth in non-malignant colonocytes.

Yoo G, Allred CD.

Food Chem Toxicol. 2016 Jan;87:23-30. doi: 10.1016/j.fct.2015.11.015.

PMID:
26593444
7.

3,3'-Diindolylmethane: A Promising Sensitizer of γ-Irradiation.

Wang W, Lv M, Huangfu C, Wang F, Zhang J.

Biomed Res Int. 2015;2015:465105. doi: 10.1155/2015/465105.

8.
9.

Desorption of 3,3'-diindolylmethane from imprinted particles: An impact of cross-linker structure on binding capacity and selectivity.

Klejn D, Luliński P, Maciejewska D.

Mater Sci Eng C Mater Biol Appl. 2015 Nov 1;56:233-40. doi: 10.1016/j.msec.2015.06.016.

PMID:
26249585
10.

The effect of oral 3,3'-diindolylmethane supplementation on the 2:16α-OHE ratio in BRCA1 mutation carriers.

Nikitina D, Llacuachaqui M, Sepkovic D, Bradlow HL, Narod SA, Kotsopoulos J.

Fam Cancer. 2015 Jun;14(2):281-6. doi: 10.1007/s10689-015-9783-2.

PMID:
25613194
11.

Low levels of 3,3'-diindolylmethane activate estrogen receptor α and induce proliferation of breast cancer cells in the absence of estradiol.

Marques M, Laflamme L, Benassou I, Cissokho C, Guillemette B, Gaudreau L.

BMC Cancer. 2014 Jul 21;14:524. doi: 10.1186/1471-2407-14-524.

12.

BRCA1 mRNA levels following a 4-6-week intervention with oral 3,3'-diindolylmethane.

Kotsopoulos J, Zhang S, Akbari M, Salmena L, Llacuachaqui M, Zeligs M, Sun P, Narod SA.

Br J Cancer. 2014 Sep 23;111(7):1269-74. doi: 10.1038/bjc.2014.391.

13.

Comparative preclinical pharmacokinetics study of 3,3'-diindolylmethane formulations: is personalized treatment and targeted chemoprevention in the horizon?

Paltsev M, Kiselev V, Muyzhnek E, Drukh V, Kuznetsov I, Pchelintseva O.

EPMA J. 2013 Dec 10;4(1):25. doi: 10.1186/1878-5085-4-25.

14.

DIM (3,3'-diindolylmethane) confers protection against ionizing radiation by a unique mechanism.

Fan S, Meng Q, Xu J, Jiao Y, Zhao L, Zhang X, Sarkar FH, Brown ML, Dritschilo A, Rosen EM.

Proc Natl Acad Sci U S A. 2013 Nov 12;110(46):18650-5. doi: 10.1073/pnas.1308206110.

15.

3,3'-diindolylmethane rapidly and selectively inhibits hepatocyte growth factor/c-Met signaling in breast cancer cells.

Nicastro HL, Firestone GL, Bjeldanes LF.

J Nutr Biochem. 2013 Nov;24(11):1882-8. doi: 10.1016/j.jnutbio.2013.05.004.

16.

Epigenetic modifications of Nrf2 by 3,3'-diindolylmethane in vitro in TRAMP C1 cell line and in vivo TRAMP prostate tumors.

Wu TY, Khor TO, Su ZY, Saw CL, Shu L, Cheung KL, Huang Y, Yu S, Kong AN.

AAPS J. 2013 Jul;15(3):864-74. doi: 10.1208/s12248-013-9493-3.

17.
18.

2,2'-diphenyl-3,3'-diindolylmethane: a potent compound induces apoptosis in breast cancer cells by inhibiting EGFR pathway.

Bhowmik A, Das N, Pal U, Mandal M, Bhattacharya S, Sarkar M, Jaisankar P, Maiti NC, Ghosh MK.

PLoS One. 2013;8(3):e59798. doi: 10.1371/journal.pone.0059798.

19.

3,3'-Diindolymethane ameliorates adriamycin-induced cardiac fibrosis via activation of a BRCA1-dependent anti-oxidant pathway.

Yao Z, Hu W, Yin S, Huang Z, Zhu Q, Chen J, Zang Y, Dong L, Zhang J.

Pharmacol Res. 2013 Apr;70(1):139-46. doi: 10.1016/j.phrs.2013.01.006.

PMID:
23376355
20.

3, 3'-Diindolylmethane enhances the effectiveness of herceptin against HER-2/neu-expressing breast cancer cells.

Ahmad A, Ali S, Ahmed A, Ali AS, Raz A, Sakr WA, Rahman KM.

PLoS One. 2013;8(1):e54657. doi: 10.1371/journal.pone.0054657.

Items per page

Supplemental Content

Loading ...
Support Center